Snowden Capital Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $428K | Buy |
|
|||||
|
2025
Q1 | $393K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $504K | Sell |
|
|||||
|
2024
Q2 | $486K | Sell |
|
|||||
|
2024
Q1 | $727K | Sell |
|
|||||
|
2023
Q4 | $722K | Buy |
|
|||||
|
2023
Q3 | $507K | Sell |
|
|||||
|
2023
Q2 | $631K | Buy |
|
|||||
|
2023
Q1 | $429K | Sell |
|
|||||
|
2022
Q4 | $621K | Buy |
|
|||||
|
2022
Q3 | $418K | Sell |
|
|||||
|
2022
Q2 | $525K | Buy |
|
|||||
|
2022
Q1 | $542K | Buy |
|
|||||
|
2021
Q4 | $483K | Sell |
|
|||||
|
2021
Q3 | $672K | Sell |
|
|||||
|
2021
Q2 | $754K | Sell |
|
|||||
|
2021
Q1 | $1.17M | Buy |
|
|||||
|
2020
Q4 | $1.21M | Sell |
|
|||||
|
2020
Q3 | $1.24M | Buy |
|
|||||
|
2020
Q2 | $768K | Buy |
|
|||||
|
2020
Q1 | $522K | Sell |
|
|||||
|
2019
Q4 | $883K | Sell |
|
|||||
|
2019
Q3 | $721K | Sell |
|
|||||
|
2019
Q2 | $1.19M | Sell |
|
|||||
|
2019
Q1 | $1.3M | Buy |
|
|||||
|
2018
Q4 | $761K | Sell |
|
|||||
|
2018
Q3 | $2.05M | Buy |
|
|||||
|
2018
Q2 | $2.01M | Buy |
|
|||||
|
2018
Q1 | $1.82M | Buy |
|
|||||
|
2017
Q4 | $1.7M | Buy |
|
|||||
|
2017
Q3 | $1.42M | Buy |
|